Clin2
NCT07510958Possibly a fitNot yet recruiting

Testing a new inhaled drug for safety in healthy adults

Healthy Participants

This trial tests a new inhaler medication to see if it is safe and how the body processes it. It may help in future treatments for lung conditions.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
84 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You have a body weight of at least 45 kg (women) or 50 kg (men) and a BMI between 19 and 28.
  • You are generally healthy with no significant lung, heart, or other chronic diseases.
  • You do not smoke more than 5 cigarettes a day and have not smoked for at least 6 months.
  • You agree to use reliable contraception if you are sexually active (no hormonal methods) and avoid donating sperm or eggs for 6 months after the trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07771777Not yet recruiting· Phase 1
Safety study of the drug SYH2056 in healthy volunteers

This early-phase trial tests a new drug, SYH2056, in healthy people to see how safe it is and how the body handles it. The study will also look at how food affects the drug. If you are generally healthy, this could be a way to contribute to medical research.

NCT07412353Recruiting· Phase 1
Testing safety of single dose SYH2085 in healthy people

This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.

Shanghai, Shanghai Municipality
NCT07301203Recruiting· Phase 1
Healthy volunteer study of inhaled CPD704

This early-phase study tests a new inhaled medication called CPD704 in healthy volunteers. It checks safety and how the body processes the drug.

Beijing, Beijing Municipality
NCT07644195Not yet recruiting· Phase 1
Testing an inhaled medication's safety in healthy people

This trial tests a new inhaled medication to see if it is safe and how it works in healthy volunteers. It may help with future lung conditions.

Lincoln, Nebraska
NCT07804628Not yet recruiting· Phase 1
Safety study of an inhaled dry powder in healthy adults

This study tests a new inhaled dry powder medicine (called ICF001) in healthy volunteers to see how safe it is and what side effects it might cause. It is a first-in-human study, so participants will help researchers understand the drug's effects and how it moves through the body.

Brisbane, Queensland
NCT07528703Not yet recruiting· Phase 1
Safety study of an inhaled powder in healthy volunteers

This study tests a new inhaled powder (RC010) to see if it is safe and how the body processes it. It is for healthy adults who do not smoke and have no major health problems.

Beijing, Beijing Municipality

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.